Both in Pharmaceuticals
Standard BioTools vs Fulcrum Therapeutics
Over the past year LAB returned −43.8% and FULC returned −57.3%; their daily moves had a correlation of 0.13.
LAB −43.8% FULC −57.3%Growth of $1, one year, split-adjusted
| Metric | LAB | FULC |
|---|---|---|
| Price | $0.7133 | $3.70 |
| Market cap | $280.0M | $282.3M |
| Today | −1.92% | −0.54% |
| 1 month | +11.1% | −3.9% |
| 6 months | −22.6% | −43.8% |
| Year to date | −44.3% | −67.3% |
| 1 year | −45.1% | −58.1% |
| Revenue growth (YoY) | −7.6% | — |
| Gross margin | 52.4% | — |
| Net margin | −133.1% | — |
| P/E (TTM) | 3.3× | — |
| Price / sales | 3.3× | — |
| Net cash | $476.4M | $318.8M |
| Dividend yield | — | — |
| Volatility (60d) | 57.7% | 25.4% |
| Short % of float | 1.1% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).